Population Proteomics in Health and Disease

Programm

• • Poster presentation
  • P-I-0205

  Plasma cytokine profiles in the SHIP-TREND-0 cohort – associations with age, sex and BMI

  • Sabine Ameling (Greifswald / DE)

   Population Proteomics in Health and Disease
• • Poster presentation
  • P-I-0206

  Pre-existing immunity effects on viral infections and vaccinations

  • Carlota Arias-Hidalgo (Salamanca / ES)

   Population Proteomics in Health and Disease
• • Poster presentation
  • P-I-0207

  Trans-pandemic population profiling in young adults

  • Annika Bendes (Solna / SE)

   Population Proteomics in Health and Disease
• • Poster presentation
  • P-I-0208

  In-depth plasma proteome from patients with post-viral neurocognitive disorders: a pilot study

  • Jonas Bergquist (Uppsala / SE)

   Population Proteomics in Health and Disease
• • Poster presentation
  • P-I-0209

  Protein signatures across multiple neurodegenerative diseases

  • Sofia Bergström (Stockholm / SE)

   Population Proteomics in Health and Disease
• • Poster presentation
  • P-I-0210

  Persistent antibody clones dominate the plasma antibody repertoire

  • Albert Bondt (Utrecht / NL)

   Population Proteomics in Health and Disease
• • Poster presentation
  • P-I-0211

  In-depth crude plasma micro-flow LC-MS/MS profiling for disease understanding and biomarkers discovery using novel tandem UHPLC workflow and on-line coupled columns

  • Oleksandr Boychenko (Wuppertal / DE)

   Population Proteomics in Health and Disease
• • Poster presentation
  • P-I-0212

  Empowering robust population-scale MS plasma proteomics studies with nanoparticle enrichment

  • Lee Cantrell (Redwood City, CA / US)

   Population Proteomics in Health and Disease
• • Poster presentation
  • P-I-0213

  Large-scale protein-disease risk association analysis in the UK Biobank: Introducing an extensive and freely available research resource in Olink^® Insight

  • Ola Caster (Uppsala / SE)
  • Ida Grundberg (Uppsala / SE)

   Population Proteomics in Health and Disease
• • Poster presentation
  • P-I-0214

  Proteomics profiling of normal and tumoral human colon stem and epithelial cell populations

  • Paula Díez (Oviedo / ES)

   Population Proteomics in Health and Disease
• • Poster presentation
  • P-I-0215

  Mitochondrial dynamics in gastric cancer: contrasting diffuse and intestinal types

  • Diana Lashidua Fernandez Coto (Cuernavaca / MX)

   Population Proteomics in Health and Disease
• • Poster presentation
  • P-I-0216

  Analyzing the proteome, N-glycoproteome and phosphoproteome of dried blood: method optimization and application to phenotyping of human sepsis

  • Matt Foster (Durham, NC / US)

   Population Proteomics in Health and Disease
• • Poster presentation
  • P-I-0218

  Exploring the spectrum of human encounters with bacterial pathogens by profiling pathogen-specific antibody repertoires in a population-based setting using the SHIP-TREND cohort

  • Marie-Sofie Illenseher (Greifswald / DE)

   Population Proteomics in Health and Disease
• • Poster presentation
  • P-I-0219

  Challenges of scientific project management in the SMART-CARE consortium

  • Roman Ladig (Heidelberg / DE)

   Population Proteomics in Health and Disease
• • Poster presentation
  • P-I-0220

  Proteomics as a bridge between genomics and human health: a systematic approach to identify therapeutic targets in large population health cohorts like the UK biobank

  • Ryan Lamers (Waltham, MA / US)

   Population Proteomics in Health and Disease
• • Poster presentation
  • P-I-0221

  Assessing the role of protein variants in modulating protein-protein interaction networks by a quantitative interactomics approach

  • Yushi Men (Illkirch / FR)

   Population Proteomics in Health and Disease
• • Poster presentation
  • P-I-0222

  Follicular fluid peptidomics: understanding Oocyte reproductive potential

  • Inez Mruk (Gdansk / PL)

   Population Proteomics in Health and Disease
• • Poster presentation
  • P-I-0223

  Facilitating large-scale proteomics by combining automated sample preparation with short gradient LC-MS acquisitions

  • Sebastian Müller (Schlieren / CH)

   Population Proteomics in Health and Disease
• • Poster presentation
  • P-I-0224

  Pediatric proteomics: a systematic approach to deciphering disease and enhancing early intervention

  • Johannes Bruno Müller-Reif (Planegg / DE)

   Population Proteomics in Health and Disease
• • Poster presentation
  • P-I-0225

  Profiling of the peripheral blood mononuclear cells proteome by shot-gun proteomics identifies alterations of immune components, proteolytic balance and mithocondrial metabolism in Glaucoma

  • Irene Pandino (Rome / IT)

   Population Proteomics in Health and Disease
• • Poster presentation
  • P-I-0226

  A network analysis approach to identify protein clusters and multi-Omic determinants of childhood respiratory-related diseases

  • Nicole Prince (Boston, MA / US)

   Population Proteomics in Health and Disease
• • Poster presentation
  • P-I-0227

  Plasma proteins associated with COVID-19 in unvaccinated and vaccinated Puerto Ricans

  • Ana Rodriguez (San Juan / PR)

   Population Proteomics in Health and Disease
• • Poster presentation
  • P-I-0228

  Proteomic profiling of cancer-associated fibroblasts in squamous cell carcinoma

  • Sibilla Sander (Fribourg / CH)

   Population Proteomics in Health and Disease
• • Poster presentation
  • P-I-0229

  Genetic atlas of human protein complexes

  • Xia Shen (Stockholm / SE)

   Population Proteomics in Health and Disease
• • Poster presentation
  • P-I-0230

  Every hour counts: mapping neonatal blood plasma proteome changes during the first 2 days of life at hourly resolution

  • Hanno Steen (Boston, MA / US)

   Population Proteomics in Health and Disease
• • Poster presentation
  • P-I-0231

  Prediction of type 1 diabetes using proteomics

  • Tomi Suomi (Turku / FI)

   Population Proteomics in Health and Disease
• • Poster presentation
  • P-I-0232

  Proteomic profiling of CSF and serum: non-linear progression and staging biomarkers for preclinical Alzheimer's disease

  • Jiayi Zhang (Shanghai / CN)

   Population Proteomics in Health and Disease